Gene mutation could spore non-inherited cancer
The research undertaken at The Ohio State University Comprehensive Cancer Center focused on the gene for type 1 transforming growth factor-beta receptor, or TGFBR1, and on a variation
Japan-based Ono Pharmaceutical has signed an agreement with US biotechnology company Aitia to collaborate on drug discovery in neurological diseases.